Identifying Diagnostic and Prognostic Biomarkers and Candidate Therapeutic Drugs of Gastric Cancer Based on Transcriptomics and Single-Cell Sequencing

被引:15
作者
Zhao, Xu [1 ]
Wu, Shuang [2 ]
Jing, Jingjing [3 ,4 ,5 ]
机构
[1] Liaoning Vocat Coll Med, Math Comp Teaching & Res Off, Shenyang, Peoples R China
[2] Changchun Normal Univ, Coll Comp Sci & Technol, Changchun, Peoples R China
[3] China Med Univ, Hosp 1, Tumor Etiol & Screening Dept, Canc Inst & Gen Surg, Shenyang, Peoples R China
[4] China Med Univ, Hosp 1, Key Lab Canc Etiol & Prevent, Liaoning Educ Dept, Shenyang, Peoples R China
[5] China Med Univ, Hosp 1, Key Lab GI Canc Etiol & Prevent Liaoning Prov, Shenyang, Peoples R China
基金
中国国家自然科学基金;
关键词
bioinformatics; biomarkers; prognosis; gastric cancer; hub genes; molecular drugs; SPARC EXPRESSION; VEGF EXPRESSION; POOR-PROGNOSIS; WEB SERVER; BIGLYCAN; PROGRESSION; INHIBITION; GENES;
D O I
10.3389/pore.2021.1609955
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objective: Gastric cancer (GC) is an important health burden and the prognosis of GC is poor. We aimed to explore new diagnostic and prognostic indicators as well as potential therapeutic targets for GC in the current study.Methods: We screened the overlapped differentially expressed genes (DEGs) from GSE54129 and TCGA STAD datasets. Protein-protein interaction network analysis recognized the hub genes among the DEGs. The roles of these genes in diagnosis, prognosis, and their relationship with immune infiltrates and drug sensitivity of GC were analyzed using R studio. Finally, the clinically significant hub genes were verified using single-cell RNA sequencing (scRNA-seq) data.Results: A total of 222 overlapping genes were screened, which were enriched in extracellular matrix-related pathways. Further, 17 hub genes were identified, and our findings demonstrated that BGN, COMP, COL5A2, and SPARC might be important diagnostic and prognostic indicators of GC, which were also correlated with immune cell infiltration, tumor mutation burden (TMB), microsatellite instability (MSI), and sensitivity of therapeutic drugs. The scRNA-seq results further confirmed that all four hub genes were highly expressed in GC.Conclusion: Based on transcriptomics and single-cell sequencing, we identified four diagnostic and prognostic biomarkers of GC, including BGN, COMP, COL5A2, and SPARC, which can help predict drug sensitivity for GC as well.
引用
收藏
页数:14
相关论文
共 36 条
  • [1] jvenn: an interactive Venn diagram viewer
    Bardou, Philippe
    Mariette, Jerome
    Escudie, Frederic
    Djemiel, Christophe
    Klopp, Christophe
    [J]. BMC BIOINFORMATICS, 2014, 15
  • [2] Checkpoint inhibition: an ATTRACTION in advanced gastric cancer?
    Chau, Ian
    [J]. LANCET, 2017, 390 (10111) : 2418 - 2419
  • [3] Che YQ, 2006, INT J MOL MED, V17, P1027
  • [4] Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is associated with sensitivity to growth inhibition by exogenous SPARC protein
    DiMartino, JF
    Lacayo, NJ
    Varadi, M
    Li, L
    Saraiya, C
    Ravindranath, Y
    Yu, R
    Sikic, B
    Raimondi, SC
    Dahl, G
    [J]. LEUKEMIA, 2006, 20 (03) : 426 - 432
  • [5] The UCSC Cancer Genomics Browser: update 2015
    Goldman, Mary
    Craft, Brian
    Swatloski, Teresa
    Cline, Melissa
    Morozova, Olena
    Diekhans, Mark
    Haussler, David
    Zhu, Jingchun
    [J]. NUCLEIC ACIDS RESEARCH, 2015, 43 (D1) : D812 - D817
  • [6] Visualizing and interpreting cancer genomics data via the Xena platform
    Goldman, Mary J.
    Craft, Brian
    Hastie, Mim
    Repecka, Kristupas
    McDade, Fran
    Kamath, Akhil
    Banerjee, Ayan
    Luo, Yunhai
    Rogers, Dave
    Brooks, Angela N.
    Zhu, Jingchun
    Haussler, David
    [J]. NATURE BIOTECHNOLOGY, 2020, 38 (06) : 675 - 678
  • [7] The role of SPARC expression in pancreatic cancer progression and patient survival
    Gundewar, Chinmay
    Sasor, Agata
    Hilmersson, Katarzyna Said
    Andersson, Roland
    Ansari, Daniel
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (09) : 1170 - 1174
  • [8] The Gene Ontology (GO) project in 2006
    Harris, Midori A.
    Clark, Jennifer I.
    Ireland, Amelia
    Lomax, Jane
    Ashburner, Michael
    Collins, Russell
    Eilbeck, Karen
    Lewis, Suzanna
    Mungall, Chris
    Richter, John
    Rubin, Gerald M.
    Shu, ShengQiang
    Blake, Judith A.
    Bult, Carol J.
    Diehl, Alexander D.
    Dolan, Mary E.
    Drabkin, Harold J.
    Eppig, Janan T.
    Hill, David P.
    Ni, Li
    Ringwald, Martin
    Balakrishnan, Rama
    Binkley, Gail
    Cherry, J. Michael
    Christie, Karen R.
    Costanzo, Maria C.
    Dong, Qing
    Engel, Stacia R.
    Fisk, Dianna G.
    Hirschman, Jodi E.
    Hitz, Benjamin C.
    Hong, Eurie L.
    Lane, Christopher
    Miyasato, Stuart
    Nash, Robert
    Sethuraman, Anand
    Skrzypek, Marek
    Theesfeld, Chandra L.
    Weng, Shuai
    Botstein, David
    Dolinski, Kara
    Oughtred, Rose
    Berardini, Tanya
    Mundodi, Suparna
    Rhee, Seung Y.
    Apweiler, Rolf
    Barrell, Daniel
    Camon, Evelyn
    Dimmer, Emily
    Mulder, Nicola
    [J]. NUCLEIC ACIDS RESEARCH, 2006, 34 : D322 - D326
  • [9] Biglycan stimulates VEGF expression in endothelial cells by activating the TLR signaling pathway
    Hu, Lei
    Zang, Ming-de
    Wang, He-xiao
    Li, Jian-fang
    Su, Li-ping
    Yan, Min
    Li, Chen
    Yang, Qiu-meng
    Liu, Bing-ya
    Zhu, Zheng-gang
    [J]. MOLECULAR ONCOLOGY, 2016, 10 (09): : 1473 - 1484
  • [10] Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer
    Jacobsen, Frank
    Kraft, Juliane
    Schroeder, Cornelia
    Hube-Magg, Claudia
    Kluth, Martina
    Lang, Dagmar S.
    Simon, Ronald
    Sauter, Guido
    Izbicki, Jakob R.
    Clauditz, Till S.
    Luebke, Andreas M.
    Hinsch, Andrea
    Wilczak, Waldemar
    Wittmer, Corinna
    Buescheck, Franziska
    Hoeflmayer, Doris
    Minner, Sarah
    Tsourlakis, Maria Christina
    Huland, Hartwig
    Graefen, Markus
    Budaeus, Lars
    Thederan, Imke
    Salomon, Georg
    Schlomm, Thorsten
    Melling, Nathaniel
    [J]. NEOPLASIA, 2017, 19 (09): : 707 - 715